)
Company research29 Apr 2026
Target Corporation: The Business Behind the Bullseye
How Target grew from a Minneapolis dry goods store into a retail giant, blending discount pricing with design and private-label power.
Oncoinvent
Oncoinvent (ONCIN) investor relations material
Oncoinvent Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary29 Apr, 2026
Executive summary
Focused on advancing a phase II trial for Radspherin in peritoneal carcinomatosis, with 37 patients recruited and 10 hospitals actively enrolling as of the quarter's end.
Achieved a new Chinese patent for Radspherin, strengthening IP protection in China.
Published clinical data in Gynecologic Oncology and presented at ESGO Conference.
Hired a new CFO, Dr. Ramzi Amri, who brings both medical and strategic expertise.
Outlook and guidance
Current cash reserves of NOK 130 million are expected to fund operations into 2027, supporting ongoing clinical R&D.
Exploring strategic partnerships, business development, and capital market opportunities to extend financial runway.
Recruitment momentum is strong, with plans to add more hospitals and optimize patient enrollment using digital tools.
Segment performance
Phase II trial in ovarian cancer is ongoing, with FDA Fast Track designation and data readouts expected in 2026–2028.
Phase I/II-A in colorectal cancer showed promising efficacy and safety, supporting further development.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Oncoinvent
- Revenue up, expenses down, merger and rights issue extend funding into 2027.ONCIN
Q2 202523 Apr 2026 - RadspherinⓇ shows promise in reducing peritoneal cancer recurrence with strong safety data.ONCIN7th Targeted Radiopharmaceuticals Summit Europe presentation23 Apr 2026
- RadspherinⓇ demonstrates strong efficacy and safety for peritoneal metastases in key cancers.ONCINDNB Carnegie Nordic Healthcare Conference presentation23 Apr 2026
- Radspherin delivers durable local control and safety for peritoneal cancers, with blockbuster potential.ONCINDNB Carnegie Nordic Healthcare Conference presentation23 Apr 2026
- RadspherinⓇ demonstrates promising efficacy and safety for peritoneal metastases in cancer.ONCINInvestor presentation23 Apr 2026
- Strong clinical progress, merger, and NOK 130M raise deliver NOK 180M cash and runway into 2027.ONCINQ4 202526 Feb 2026
- Bemcentinib advances in STK11-mutated NSCLC, with strong safety, lower costs, and solid cash runway.ONCINQ3 20243 Feb 2026
- Phase 2a in STK11m NSCLC advances, fully funded, with key data and Tempus control arm ahead.ONCINQ2 202423 Jan 2026
- All proposals for share capital changes and board authorizations were approved by shareholders.ONCINEGM 20268 Jan 2026
Next Oncoinvent earnings date
Q2 202627 Aug, 2026
Oncoinvent
Next Oncoinvent earnings date
Q2 202627 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
Business philosophy23 Apr 2026
Greg Foran: The New CEO of Kroger
How Greg Foran rose from store floor to CEO of Kroger, led Walmart's turnaround, and built a leadership style focused on execution.
)
Company research22 Apr 2026
Companies That Had Their IPO in 2025: The IPO Market Recovers
After years of uncertainty, 2025 marked the IPO market's return, with major listings like Klarna and Figma signaling renewed momentum.
Frequently asked questions
Explore our global coverage